Akoya Biosciences, Inc. (AKYA)
Jul 8, 2025 - AKYA was delisted (reason: acquired by QTRX)
1.290
0.00 (0.00%)
Inactive · Last trade price
on Jul 7, 2025
Akoya Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Net Income | -47.53 | -55.37 | -63.32 | -70.64 | -42.94 | -16.71 | Upgrade
|
| Depreciation & Amortization | 7.4 | 7.65 | 8.89 | 7.15 | 4.79 | 3.82 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | 0.08 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 2.97 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.3 | -1.66 | -0.01 | -0.22 | - | - | Upgrade
|
| Stock-Based Compensation | 8.99 | 9.31 | 10.44 | 7.43 | 4.04 | 0.48 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.6 | 0.92 | - | - | - | - | Upgrade
|
| Other Operating Activities | 3.88 | 5.96 | 7.58 | 2.55 | 2.6 | 3.18 | Upgrade
|
| Change in Accounts Receivable | 1.14 | 2.3 | -7.27 | -0.29 | -2.97 | 6.7 | Upgrade
|
| Change in Inventory | -1.55 | -9.86 | -6.33 | -5.37 | -4.63 | -0.68 | Upgrade
|
| Change in Accounts Payable | -0.46 | -3.02 | 1.15 | 1.19 | 4.36 | -3.05 | Upgrade
|
| Change in Unearned Revenue | -0.24 | -0.26 | 1.49 | 2.58 | 0.96 | -0.43 | Upgrade
|
| Change in Other Net Operating Assets | -1.41 | -3.05 | -3.52 | 2.04 | -2.28 | -0.15 | Upgrade
|
| Operating Cash Flow | -30.49 | -44.1 | -50.9 | -53.5 | -36.07 | -6.84 | Upgrade
|
| Capital Expenditures | -1.85 | -2.46 | -3.65 | -7.36 | -5.09 | -3.3 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 0.06 | - | - | Upgrade
|
| Investment in Securities | 42.66 | -21.6 | 7 | -6.77 | - | 10.02 | Upgrade
|
| Investing Cash Flow | 40.81 | -24.05 | 3.35 | -14.08 | -5.09 | 6.73 | Upgrade
|
| Long-Term Debt Issued | - | - | 11.25 | 31.25 | - | 34.98 | Upgrade
|
| Long-Term Debt Repaid | - | -1.02 | -0.68 | -0.62 | -0.32 | -25.19 | Upgrade
|
| Net Debt Issued (Repaid) | -1.02 | -1.02 | 10.57 | 30.63 | -0.32 | 9.79 | Upgrade
|
| Issuance of Common Stock | 0.06 | 0.09 | 48.31 | 0.45 | 138.95 | 0.12 | Upgrade
|
| Repurchase of Common Stock | -0.14 | -0.21 | -0.09 | - | - | - | Upgrade
|
| Other Financing Activities | -1.91 | -2.06 | -1.95 | -2.35 | -1.59 | -4.42 | Upgrade
|
| Financing Cash Flow | -3.01 | -3.21 | 56.84 | 28.73 | 137.04 | 5.49 | Upgrade
|
| Net Cash Flow | 7.31 | -71.36 | 9.29 | -38.85 | 95.87 | 5.37 | Upgrade
|
| Free Cash Flow | -32.34 | -46.56 | -54.55 | -60.86 | -41.16 | -10.14 | Upgrade
|
| Free Cash Flow Margin | -40.45% | -57.01% | -56.45% | -81.29% | -74.95% | -23.89% | Upgrade
|
| Free Cash Flow Per Share | -0.65 | -0.94 | -1.23 | -1.61 | -1.53 | -4.28 | Upgrade
|
| Cash Interest Paid | 9.06 | 9.18 | 7.65 | 3.48 | 2.67 | 2.25 | Upgrade
|
| Cash Income Tax Paid | 0.09 | 0.09 | 0.06 | - | - | - | Upgrade
|
| Levered Free Cash Flow | -15.14 | -26.52 | -34.04 | -34.24 | -26.04 | -5.5 | Upgrade
|
| Unlevered Free Cash Flow | -8.7 | -20 | -28.56 | -31.39 | -24.1 | -3.8 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.